Crescent Capital BDC, Inc. (CCAP) - Q2 2020 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2020. Crescent Capital BDC, Inc. is a closed-end, externally managed business development company (BDC) and regulated investment company (RIC). The reporting period was significantly impacted by the completion of the Alcentra Capital Corporation acquisition on January 31, 2020, which was accounted for as an asset acquisition. The Company also listed on the NASDAQ on February 3, 2020.
Key Financial Metrics
| Metric | Q2 2020 (3 Months) | YTD 2020 (6 Months) | YTD 2019 (6 Months) |
|---|---|---|---|
| Total Investment Income | $19.3 million | $38.2 million | $24.0 million |
| Net Investment Income | $13.0 million | $24.5 million | $14.2 million |
| Net Realized & Unrealized Gains (Losses) | $43.7 million | $(39.1) million | $3.6 million |
| Net Increase (Decrease) in Net Assets | $56.4 million | $(18.1) million | $17.4 million |
| Net Asset Value (NAV) per Share | $18.12 | $18.12 | $19.75 |
| Total Debt (Carrying Value) | $403.4 million | $403.4 million | $275.9 million |
| Cash & Restricted Cash | $11.6 million | $11.6 million | $9.0 million |
Material Changes vs. Prior Period
- Portfolio Growth: Total investments at fair value increased to $895.2 million from $726.5 million at year-end 2019, driven primarily by the Alcentra Acquisition ($195.7 million in assets acquired) and organic deployment.
- Volatility Impact: The six-month period ended June 30, 2020, recorded a net decrease in net assets of $18.1 million, contrasting with a $17.4 million increase in the prior year. This was primarily due to a $37.9 million net unrealized depreciation on investments, attributed to market volatility and wider credit spreads resulting from the COVID-19 pandemic.
- Asset Acquisition Loss: A one-time $3.8 million realized loss was recorded in the six-month period related to the Alcentra Acquisition, as the total consideration paid exceeded the fair value of net assets acquired.
- Expense Structure: Net expenses increased to $13.3 million (YTD 2020) from $9.8 million (YTD 2019). However, the Advisor waived significant management and incentive fees ($6.5 million total waivers YTD 2020) to support stockholders following the merger.
- Debt Levels: Total debt increased to $400.3 million (drawn) from $325.4 million at year-end 2019, reflecting the assumption of Alcentra's debt and increased leverage to fund the portfolio. The weighted average interest rate decreased to 2.67% from 4.10% due to lower benchmark rates.
Guidance, Outlook, and Risks
- Fee Waivers: The Advisor has agreed to waive a portion of the management fee (reducing the effective rate to 0.75% annually) and the income-based incentive fee through July 31, 2021.
- Dividends: The Company declared a regular cash dividend of $0.41 per share for the quarter ended June 30, 2020. A subsequent dividend of $0.41 per share was declared on August 7, 2020.
- Liquidity: As of June 30, 2020, the Company had $166.1 million of undrawn capacity on its credit facilities. Management is monitoring liquidity closely due to the pandemic, noting that high market spreads may impact collateral eligibility.
- Risk Factors: Key risks include the impact of COVID-19 on portfolio companies, potential defaults, illiquidity of investments, and the uncertainty of the financial stability of the U.S. and global markets. The Company had 5 portfolio companies on non-accrual status as of June 30, 2020 (3.9% of debt at cost).
Investor Verification Checklist
- Verify the sustainability of the fee waivers (management and incentive) and their expiration date (July 31, 2021).
- Review the non-accrual portfolio details (5 companies, 8 positions) to assess credit risk exposure.
- Confirm the asset coverage ratio (2.26x) remains compliant with the 1940 Act requirements (minimum 150% with shareholder approval).
- Monitor the unfunded commitments ($66.6 million) and the Company's ability to fund them given current liquidity constraints.
- Assess the impact of the Alcentra Acquisition integration on future operating expenses and portfolio yield.